OTCM
ACAN
Market cap4kUSD
Oct 06, Last price
0.00USD
Jan 2017
-99.99%
IPO
-100.00%
Name
Americann Inc
Chart & performance
P/E
—
P/S
0.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
1.20%
Rev. gr., 5y
156.14%
Revenues
1m
-50.04%
Net income
-1m
L+1,223.41%
CFO
-1m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
AmeriCann, Inc., with its headquarters in Denver, Colorado, functions as a specialized cannabis enterprise throughout the United States. The company offers a complete range of services to authorized cannabis businesses, handling the conception, construction, leasing, and daily management of facilities crucial for cultivating, processing, and manufacturing cannabis products. A significant venture for the firm is the Massachusetts Cannabis Center, an extensive development located on a 52-acre property in Freetown, southeastern Massachusetts. Furthermore, AmeriCann supplies cannabis for both medical applications and adult recreational consumption. Incorporated in 2010, the organization initially operated as Nevada Health Scan, Inc., eventually rebranding to AmeriCann, Inc. in 2014.
Key people
Benjamin J. Barton
Chief Financial Officer, Chief Accounting Officer, Director · since 2014
J. Tyler Opel
Director · since 2019
Legal address
C/O INCORP SERVICES, INC.
131 CONTINENTAL DRIVE
SUITE 301
NEWARK, DE 19713
US
131 CONTINENTAL DRIVE
SUITE 301
NEWARK, DE 19713
US
Headquarters
1 Commerce Center
1201 Orange Street
Suite 600
Wilmington, DE 19899
US
1201 Orange Street
Suite 600
Wilmington, DE 19899
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||